0
Upcoming Allied Market Research
2023
Onco-nutrition And Supplements Market

Onco-Nutrition and Supplements Market: Global Opportunity Analysis and Industry Forecast, 2023-2030 Market

Report Code: A10905
Nov 2023 | Pages: NA
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Onco-nutrition And Supplements Market

Request Now !

Onco-Nutrition and Supplements Market Outlook - 2027

The nutritional status of patient suffering with cancer is affected negatively due to cancer itself or indirectly via tumor-induced metabolic changes also referred to as cancer cachexia or cancer-induced malnutrition. Most of the oncology treatments cause side effects that reduce appetite and food intake. Some of these adverse effects persist for long-term. Hence, proper nutrition during oncology therapeutics is crucial. Appropriate nutrition is clinical for maintaining proper health during and post cancer treatment. Research and studies have also found evidences regarding the proper nutrition that helps in boosting the immunity and aids in prevention of cancer and simultaneously increases the effectiveness of cancer therapeutics. Oncology patients understand the importance of essential nutrition as it has enormous effect on the treatment. Consuming a variety of foods containing nutritional elements and well-balanced meals assist them in staying stronger during the course of treatment.  It also aids in maintaining proper body weight, preserving optimal levels of energy and strength, reduces the risk and complications related to infection and helps in rapid recovery. High protein diets are recommended for patients suffering from cancer.

COVID – 19 scenario analysis:

  • Due to the COVID – 19  outbreak, majority of healthcare, pharmaceutical and biotechnology organizations have concentrated on diagnostics kits, safety wearables (PPE kits, face shields, masks) and treatment therapies and medication against Novel coronavirus
  • R&D labs are also focusing on finding a breakthrough vaccine against Novel coronavirus
  • In addition, the medical professionals are engaged in providing COVID-19 related services, as a result, other healthcare segments  have to face negligence
  • As there is strain on healthcare providers and the hospitals are flooding with patients suffering with SARS-CoV-2 and the intake capacity of hospitals already at its peak
  • Due to diversion of medical field towards treating COVID-19, the funding to R&D activities related to oncology nutrition has been reduced and this segment have to face negligence subsequently causing negative impact on onco-nutrition and supplements market
  • Some research from China, has also stated that cancer patients are at higher risk as they’re vulnerable against SARS-CoV-2 and have higher chances of getting infected with the virus

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

The onco-nutrition and supplements market is expected to witness significant growth in coming years due to factors such as increasing prevalence of cancer creating large patient pools, shifting focus to enteral from parenteral nutrition, rising demand for appropriate nutritional intake in cancer patients, rising incidences of patients suffering with malnutrition due to cancer itself as well as cancer therapies, and increasing clinical research in the field of nutritional interventions in disease management. The other factors like the increasing demand for nutritional products, availability of nutritional consumables and rising need to meet oncology patient’s daily nutritional intake. Furthermore, the rising requirement related to enteral nutrition for patients suffering with head and neck cancer would facilitate the market growth. Increasing number of cancer patients surge the uptake of tube feeding formulas, which helps in proper nutritional intake in extreme medical conditions due to cancer. Hence, the rise in the enteral nutrition will stimulate the growth of onco-nutrition and supplements market.

On the contrary, the unfavorable reimbursement policies related with the tube feeding systems and negligence of importance of nutrition in cancer therapeutics and recovery are some factors anticipated to impede the growth of the onco-nutrition and supplements market to a certain extent.

Having said that, drastic rise in demand for meeting nutritional intake in the homecare settings coupled with high usage of nutritional supplements will amplify the market growth and create growth and market expansion opportunities for the onco-nutrition and supplements market. Statistics further suggest that approximately 1.5 million people in the U.S. are diagnosed with some form of cancer every year which facilitates the higher consumption of nutritional supplements including herbs, vitamins, and extracts that aid in strengthening the immunity and provide relief from adverse effects of radiation and chemotherapy.

Dietary factors and changing lifestyle to propel the market

Dietary factors play a pivotal role in the acquiring and treatment of cancer. Unhealthy diet coupled with unhealthy lifestyle increase chances of getting affected with cancer. Obesity and diet can be directly associated with almost 30% to 35% of fatalities caused due to cancer, while lethargic lifestyle and physical inactivity results in 7% cancer risk. Almost 85% of all cancer cases around the world are linked with changing diet and lifestyle. Food and nutritional intake significantly contributes to cancer development on one hand and cancer prevention and effective management on the other. Clinical research outcomes are constantly being upgraded by using Oncology Nutrition in integration with therapeutics as a holistic approach to oncology. Thus the change in dietary factors coupled with lethargic lifestyle would fuel the market growth. Also, the World Health Organization (WHO) in their report, mentioned the rate of obesity has tripled since 1975 worldwide. Year 2016 saw over 1.9 billion adults belonging to age group 18 years or above were overweight and out of them, over one third of people were obese. As a result, problems arising due to obesity would create demand for onco-nutrition and supplements thereby propelling the market growth.

Rising prevalence of cancer to boost the growth

According to the Cancer Research UK, around 17 million cancer cases were registered in 2018, out of which 56% of the cases were fatal. There are many key factors that may affect the success rate of chemo and radiation therapy and a person's survival rate such as age, overall health and cancer stage. As per a research report by the World Health Organization (WHO), in low- and middle-income countries, around 70% of deaths occurs due to cancer. Increase in smoking habits, genetic mutation, alcohol and hormones consumption, urban air pollution are the frequent reasons for the increasing number of cancer patients in the world. Rising number of cancer across the globe is proving to be significant for boosting the growth of onco-nutrition and supplements market.


Key benefits of the report:

  • This study presents the analytical depiction of the global onco-nutrition and supplements industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global onco-nutrition and supplements market share.
  • The current market is quantitatively analyzed to highlight the global onco-nutrition and supplements market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global onco-nutrition and supplements market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Onco-nutrition and supplements Market research report:

  • What are the leading market players active in the onco-nutrition and supplements market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?

Onco-Nutrition and Supplements Market: Global Opportunity Analysis and Industry Forecast, 2020-2027 Report Highlights

Aspects Details
By Cancer Type
  • Blood Cancer
  • Liver Cancer
  • Pancreatic Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Head and Neck Cancer
  • Lung Cancer
  • Stomach Cancer
  • Gastrointestinal Cancer
  • Others
By Distribution Channel
  • Hospital Stores
  • Retail Pharmacy
  • Online Pharmacy
By End User
  • Hospitals
  • Cancer Care Centers
  • Specialty Clinics
  • Homecare Centers
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, Uk, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (Japan, China, India, Australia, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Danone, Mead Johnson Nutrition Company, Meiji Holdings., Abbott Laboratories, Hormel Foods, Fresenius Kabi AG, Global Health Products, Nestle S.A, Victus, B. Braun Melsungen AG
Other Players Pfizer Inc., Grifols S.A., Baxter International, Inc
 
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: ONCO-NUTRITION AND SUPPLEMENTS MARKET, BY CANCER TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Cancer Type

    • 4.2. Blood Cancer

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Liver Cancer

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Pancreatic Cancer

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Breast Cancer

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. Colorectal Cancer

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

    • 4.7. Head And Neck Cancer

      • 4.7.1. Key Market Trends, Growth Factors and Opportunities

      • 4.7.2. Market Size and Forecast, By Region

      • 4.7.3. Market Share Analysis, By Country

    • 4.8. Lung Cancer

      • 4.8.1. Key Market Trends, Growth Factors and Opportunities

      • 4.8.2. Market Size and Forecast, By Region

      • 4.8.3. Market Share Analysis, By Country

    • 4.9. Stomach Cancer

      • 4.9.1. Key Market Trends, Growth Factors and Opportunities

      • 4.9.2. Market Size and Forecast, By Region

      • 4.9.3. Market Share Analysis, By Country

    • 4.10. Gastrointestinal Cancer

      • 4.10.1. Key Market Trends, Growth Factors and Opportunities

      • 4.10.2. Market Size and Forecast, By Region

      • 4.10.3. Market Share Analysis, By Country

    • 4.11. Others

      • 4.11.1. Key Market Trends, Growth Factors and Opportunities

      • 4.11.2. Market Size and Forecast, By Region

      • 4.11.3. Market Share Analysis, By Country

  • CHAPTER 5: ONCO-NUTRITION AND SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Distribution Channel

    • 5.2. Hospital Stores

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Retail Pharmacy

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Online Pharmacy

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: ONCO-NUTRITION AND SUPPLEMENTS MARKET, BY END USER

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End User

    • 6.2. Hospitals

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Cancer Care Centers

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Specialty Clinics

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Homecare Centers

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

    • 6.6. Others

      • 6.6.1. Key Market Trends, Growth Factors and Opportunities

      • 6.6.2. Market Size and Forecast, By Region

      • 6.6.3. Market Share Analysis, By Country

  • CHAPTER 7: ONCO-NUTRITION AND SUPPLEMENTS MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Cancer Type

      • 7.2.3. Market Size and Forecast, By Distribution Channel

      • 7.2.4. Market Size and Forecast, By End User

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Onco-nutrition And Supplements Market

        • 7.2.6.1. Market Size and Forecast, By Cancer Type
        • 7.2.6.2. Market Size and Forecast, By Distribution Channel
        • 7.2.6.3. Market Size and Forecast, By End User
      • 7.2.7. Canada Onco-nutrition And Supplements Market

        • 7.2.7.1. Market Size and Forecast, By Cancer Type
        • 7.2.7.2. Market Size and Forecast, By Distribution Channel
        • 7.2.7.3. Market Size and Forecast, By End User
      • 7.2.8. Mexico Onco-nutrition And Supplements Market

        • 7.2.8.1. Market Size and Forecast, By Cancer Type
        • 7.2.8.2. Market Size and Forecast, By Distribution Channel
        • 7.2.8.3. Market Size and Forecast, By End User
    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Cancer Type

      • 7.3.3. Market Size and Forecast, By Distribution Channel

      • 7.3.4. Market Size and Forecast, By End User

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Onco-nutrition And Supplements Market

        • 7.3.6.1. Market Size and Forecast, By Cancer Type
        • 7.3.6.2. Market Size and Forecast, By Distribution Channel
        • 7.3.6.3. Market Size and Forecast, By End User
      • 7.3.7. Germany Onco-nutrition And Supplements Market

        • 7.3.7.1. Market Size and Forecast, By Cancer Type
        • 7.3.7.2. Market Size and Forecast, By Distribution Channel
        • 7.3.7.3. Market Size and Forecast, By End User
      • 7.3.8. Italy Onco-nutrition And Supplements Market

        • 7.3.8.1. Market Size and Forecast, By Cancer Type
        • 7.3.8.2. Market Size and Forecast, By Distribution Channel
        • 7.3.8.3. Market Size and Forecast, By End User
      • 7.3.9. Spain Onco-nutrition And Supplements Market

        • 7.3.9.1. Market Size and Forecast, By Cancer Type
        • 7.3.9.2. Market Size and Forecast, By Distribution Channel
        • 7.3.9.3. Market Size and Forecast, By End User
      • 7.3.10. UK Onco-nutrition And Supplements Market

        • 7.3.10.1. Market Size and Forecast, By Cancer Type
        • 7.3.10.2. Market Size and Forecast, By Distribution Channel
        • 7.3.10.3. Market Size and Forecast, By End User
      • 7.3.11. Russia Onco-nutrition And Supplements Market

        • 7.3.11.1. Market Size and Forecast, By Cancer Type
        • 7.3.11.2. Market Size and Forecast, By Distribution Channel
        • 7.3.11.3. Market Size and Forecast, By End User
      • 7.3.12. Rest Of Europe Onco-nutrition And Supplements Market

        • 7.3.12.1. Market Size and Forecast, By Cancer Type
        • 7.3.12.2. Market Size and Forecast, By Distribution Channel
        • 7.3.12.3. Market Size and Forecast, By End User
    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Cancer Type

      • 7.4.3. Market Size and Forecast, By Distribution Channel

      • 7.4.4. Market Size and Forecast, By End User

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Onco-nutrition And Supplements Market

        • 7.4.6.1. Market Size and Forecast, By Cancer Type
        • 7.4.6.2. Market Size and Forecast, By Distribution Channel
        • 7.4.6.3. Market Size and Forecast, By End User
      • 7.4.7. Japan Onco-nutrition And Supplements Market

        • 7.4.7.1. Market Size and Forecast, By Cancer Type
        • 7.4.7.2. Market Size and Forecast, By Distribution Channel
        • 7.4.7.3. Market Size and Forecast, By End User
      • 7.4.8. India Onco-nutrition And Supplements Market

        • 7.4.8.1. Market Size and Forecast, By Cancer Type
        • 7.4.8.2. Market Size and Forecast, By Distribution Channel
        • 7.4.8.3. Market Size and Forecast, By End User
      • 7.4.9. South Korea Onco-nutrition And Supplements Market

        • 7.4.9.1. Market Size and Forecast, By Cancer Type
        • 7.4.9.2. Market Size and Forecast, By Distribution Channel
        • 7.4.9.3. Market Size and Forecast, By End User
      • 7.4.10. Australia Onco-nutrition And Supplements Market

        • 7.4.10.1. Market Size and Forecast, By Cancer Type
        • 7.4.10.2. Market Size and Forecast, By Distribution Channel
        • 7.4.10.3. Market Size and Forecast, By End User
      • 7.4.11. Thailand Onco-nutrition And Supplements Market

        • 7.4.11.1. Market Size and Forecast, By Cancer Type
        • 7.4.11.2. Market Size and Forecast, By Distribution Channel
        • 7.4.11.3. Market Size and Forecast, By End User
      • 7.4.12. Malaysia Onco-nutrition And Supplements Market

        • 7.4.12.1. Market Size and Forecast, By Cancer Type
        • 7.4.12.2. Market Size and Forecast, By Distribution Channel
        • 7.4.12.3. Market Size and Forecast, By End User
      • 7.4.13. Indonesia Onco-nutrition And Supplements Market

        • 7.4.13.1. Market Size and Forecast, By Cancer Type
        • 7.4.13.2. Market Size and Forecast, By Distribution Channel
        • 7.4.13.3. Market Size and Forecast, By End User
      • 7.4.14. Rest of Asia Pacific Onco-nutrition And Supplements Market

        • 7.4.14.1. Market Size and Forecast, By Cancer Type
        • 7.4.14.2. Market Size and Forecast, By Distribution Channel
        • 7.4.14.3. Market Size and Forecast, By End User
    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Cancer Type

      • 7.5.3. Market Size and Forecast, By Distribution Channel

      • 7.5.4. Market Size and Forecast, By End User

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Onco-nutrition And Supplements Market

        • 7.5.6.1. Market Size and Forecast, By Cancer Type
        • 7.5.6.2. Market Size and Forecast, By Distribution Channel
        • 7.5.6.3. Market Size and Forecast, By End User
      • 7.5.7. South Africa Onco-nutrition And Supplements Market

        • 7.5.7.1. Market Size and Forecast, By Cancer Type
        • 7.5.7.2. Market Size and Forecast, By Distribution Channel
        • 7.5.7.3. Market Size and Forecast, By End User
      • 7.5.8. Saudi Arabia Onco-nutrition And Supplements Market

        • 7.5.8.1. Market Size and Forecast, By Cancer Type
        • 7.5.8.2. Market Size and Forecast, By Distribution Channel
        • 7.5.8.3. Market Size and Forecast, By End User
      • 7.5.9. UAE Onco-nutrition And Supplements Market

        • 7.5.9.1. Market Size and Forecast, By Cancer Type
        • 7.5.9.2. Market Size and Forecast, By Distribution Channel
        • 7.5.9.3. Market Size and Forecast, By End User
      • 7.5.10. Argentina Onco-nutrition And Supplements Market

        • 7.5.10.1. Market Size and Forecast, By Cancer Type
        • 7.5.10.2. Market Size and Forecast, By Distribution Channel
        • 7.5.10.3. Market Size and Forecast, By End User
      • 7.5.11. Rest of LAMEA Onco-nutrition And Supplements Market

        • 7.5.11.1. Market Size and Forecast, By Cancer Type
        • 7.5.11.2. Market Size and Forecast, By Distribution Channel
        • 7.5.11.3. Market Size and Forecast, By End User
  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning,2022

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Abbott Laboratories

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Nestle S.A

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Fresenius Kabi AG

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Danone

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. B. Braun Melsungen AG

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Global Health Products

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Hormel Foods

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. Mead Johnson Nutrition Company

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Victus

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Meiji Holdings.

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET, BY CANCER TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR BLOOD CANCER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR LIVER CANCER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR PANCREATIC CANCER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR BREAST CANCER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR COLORECTAL CANCER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR HEAD AND NECK CANCER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR LUNG CANCER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR STOMACH CANCER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR GASTROINTESTINAL CANCER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR HOSPITAL STORES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR RETAIL PHARMACY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR ONLINE PHARMACY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 17. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR CANCER CARE CENTERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR SPECIALTY CLINICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR HOMECARE CENTERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 21. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 22. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 23. NORTH AMERICA ONCO-NUTRITION AND SUPPLEMENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 24. NORTH AMERICA ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2022-2032 ($MILLION)
  • TABLE 25. NORTH AMERICA ONCO-NUTRITION AND SUPPLEMENTS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 26. NORTH AMERICA ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 27. U.S. ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2022-2032 ($MILLION)
  • TABLE 28. U.S. ONCO-NUTRITION AND SUPPLEMENTS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 29. U.S. ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 30. CANADA ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2022-2032 ($MILLION)
  • TABLE 31. CANADA ONCO-NUTRITION AND SUPPLEMENTS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 32. CANADA ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 33. MEXICO ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2022-2032 ($MILLION)
  • TABLE 34. MEXICO ONCO-NUTRITION AND SUPPLEMENTS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 35. MEXICO ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 36. EUROPE ONCO-NUTRITION AND SUPPLEMENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 37. EUROPE ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2022-2032 ($MILLION)
  • TABLE 38. EUROPE ONCO-NUTRITION AND SUPPLEMENTS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 39. EUROPE ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 40. FRANCE ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2022-2032 ($MILLION)
  • TABLE 41. FRANCE ONCO-NUTRITION AND SUPPLEMENTS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 42. FRANCE ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 43. GERMANY ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2022-2032 ($MILLION)
  • TABLE 44. GERMANY ONCO-NUTRITION AND SUPPLEMENTS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 45. GERMANY ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 46. ITALY ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2022-2032 ($MILLION)
  • TABLE 47. ITALY ONCO-NUTRITION AND SUPPLEMENTS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 48. ITALY ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 49. SPAIN ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2022-2032 ($MILLION)
  • TABLE 50. SPAIN ONCO-NUTRITION AND SUPPLEMENTS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 51. SPAIN ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 52. UK ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2022-2032 ($MILLION)
  • TABLE 53. UK ONCO-NUTRITION AND SUPPLEMENTS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 54. UK ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 55. RUSSIA ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2022-2032 ($MILLION)
  • TABLE 56. RUSSIA ONCO-NUTRITION AND SUPPLEMENTS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 57. RUSSIA ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 58. REST OF EUROPE ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2022-2032 ($MILLION)
  • TABLE 59. REST OF EUROPE ONCO-NUTRITION AND SUPPLEMENTS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 60. REST OF EUROPE ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 61. ASIA-PACIFIC ONCO-NUTRITION AND SUPPLEMENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 62. ASIA-PACIFIC ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2022-2032 ($MILLION)
  • TABLE 63. ASIA-PACIFIC ONCO-NUTRITION AND SUPPLEMENTS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 64. ASIA-PACIFIC ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 65. CHINA ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2022-2032 ($MILLION)
  • TABLE 66. CHINA ONCO-NUTRITION AND SUPPLEMENTS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 67. CHINA ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 68. JAPAN ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2022-2032 ($MILLION)
  • TABLE 69. JAPAN ONCO-NUTRITION AND SUPPLEMENTS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 70. JAPAN ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 71. INDIA ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2022-2032 ($MILLION)
  • TABLE 72. INDIA ONCO-NUTRITION AND SUPPLEMENTS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 73. INDIA ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 74. SOUTH KOREA ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2022-2032 ($MILLION)
  • TABLE 75. SOUTH KOREA ONCO-NUTRITION AND SUPPLEMENTS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 76. SOUTH KOREA ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 77. AUSTRALIA ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2022-2032 ($MILLION)
  • TABLE 78. AUSTRALIA ONCO-NUTRITION AND SUPPLEMENTS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 79. AUSTRALIA ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 80. THAILAND ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2022-2032 ($MILLION)
  • TABLE 81. THAILAND ONCO-NUTRITION AND SUPPLEMENTS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 82. THAILAND ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 83. MALAYSIA ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2022-2032 ($MILLION)
  • TABLE 84. MALAYSIA ONCO-NUTRITION AND SUPPLEMENTS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 85. MALAYSIA ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 86. INDONESIA ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2022-2032 ($MILLION)
  • TABLE 87. INDONESIA ONCO-NUTRITION AND SUPPLEMENTS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 88. INDONESIA ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 89. REST OF ASIA PACIFIC ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2022-2032 ($MILLION)
  • TABLE 90. REST OF ASIA PACIFIC ONCO-NUTRITION AND SUPPLEMENTS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 91. REST OF ASIA PACIFIC ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 92. LAMEA ONCO-NUTRITION AND SUPPLEMENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 93. LAMEA ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2022-2032 ($MILLION)
  • TABLE 94. LAMEA ONCO-NUTRITION AND SUPPLEMENTS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 95. LAMEA ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 96. BRAZIL ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2022-2032 ($MILLION)
  • TABLE 97. BRAZIL ONCO-NUTRITION AND SUPPLEMENTS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 98. BRAZIL ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 99. SOUTH AFRICA ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2022-2032 ($MILLION)
  • TABLE 100. SOUTH AFRICA ONCO-NUTRITION AND SUPPLEMENTS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 101. SOUTH AFRICA ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 102. SAUDI ARABIA ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2022-2032 ($MILLION)
  • TABLE 103. SAUDI ARABIA ONCO-NUTRITION AND SUPPLEMENTS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 104. SAUDI ARABIA ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 105. UAE ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2022-2032 ($MILLION)
  • TABLE 106. UAE ONCO-NUTRITION AND SUPPLEMENTS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 107. UAE ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 108. ARGENTINA ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2022-2032 ($MILLION)
  • TABLE 109. ARGENTINA ONCO-NUTRITION AND SUPPLEMENTS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 110. ARGENTINA ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 111. REST OF LAMEA ONCO-NUTRITION AND SUPPLEMENTS, BY CANCER TYPE, 2022-2032 ($MILLION)
  • TABLE 112. REST OF LAMEA ONCO-NUTRITION AND SUPPLEMENTS, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 113. REST OF LAMEA ONCO-NUTRITION AND SUPPLEMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 114. ABBOTT LABORATORIES: KEY EXECUTIVES
  • TABLE 115. ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 116. ABBOTT LABORATORIES: OPERATING SEGMENTS
  • TABLE 117. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 118. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 119. NESTLE S.A: KEY EXECUTIVES
  • TABLE 120. NESTLE S.A: COMPANY SNAPSHOT
  • TABLE 121. NESTLE S.A: OPERATING SEGMENTS
  • TABLE 122. NESTLE S.A: PRODUCT PORTFOLIO
  • TABLE 123. NESTLE S.A: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 124. FRESENIUS KABI AG: KEY EXECUTIVES
  • TABLE 125. FRESENIUS KABI AG: COMPANY SNAPSHOT
  • TABLE 126. FRESENIUS KABI AG: OPERATING SEGMENTS
  • TABLE 127. FRESENIUS KABI AG: PRODUCT PORTFOLIO
  • TABLE 128. FRESENIUS KABI AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 129. DANONE: KEY EXECUTIVES
  • TABLE 130. DANONE: COMPANY SNAPSHOT
  • TABLE 131. DANONE: OPERATING SEGMENTS
  • TABLE 132. DANONE: PRODUCT PORTFOLIO
  • TABLE 133. DANONE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 134. B. BRAUN MELSUNGEN AG: KEY EXECUTIVES
  • TABLE 135. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
  • TABLE 136. B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
  • TABLE 137. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
  • TABLE 138. B. BRAUN MELSUNGEN AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 139. GLOBAL HEALTH PRODUCTS: KEY EXECUTIVES
  • TABLE 140. GLOBAL HEALTH PRODUCTS: COMPANY SNAPSHOT
  • TABLE 141. GLOBAL HEALTH PRODUCTS: OPERATING SEGMENTS
  • TABLE 142. GLOBAL HEALTH PRODUCTS: PRODUCT PORTFOLIO
  • TABLE 143. GLOBAL HEALTH PRODUCTS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 144. HORMEL FOODS: KEY EXECUTIVES
  • TABLE 145. HORMEL FOODS: COMPANY SNAPSHOT
  • TABLE 146. HORMEL FOODS: OPERATING SEGMENTS
  • TABLE 147. HORMEL FOODS: PRODUCT PORTFOLIO
  • TABLE 148. HORMEL FOODS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 149. MEAD JOHNSON NUTRITION COMPANY: KEY EXECUTIVES
  • TABLE 150. MEAD JOHNSON NUTRITION COMPANY: COMPANY SNAPSHOT
  • TABLE 151. MEAD JOHNSON NUTRITION COMPANY: OPERATING SEGMENTS
  • TABLE 152. MEAD JOHNSON NUTRITION COMPANY: PRODUCT PORTFOLIO
  • TABLE 153. MEAD JOHNSON NUTRITION COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 154. VICTUS: KEY EXECUTIVES
  • TABLE 155. VICTUS: COMPANY SNAPSHOT
  • TABLE 156. VICTUS: OPERATING SEGMENTS
  • TABLE 157. VICTUS: PRODUCT PORTFOLIO
  • TABLE 158. VICTUS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 159. MEIJI HOLDINGS.: KEY EXECUTIVES
  • TABLE 160. MEIJI HOLDINGS.: COMPANY SNAPSHOT
  • TABLE 161. MEIJI HOLDINGS.: OPERATING SEGMENTS
  • TABLE 162. MEIJI HOLDINGS.: PRODUCT PORTFOLIO
  • TABLE 163. MEIJI HOLDINGS.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET SEGMENTATION
  • FIGURE 2. GLOBAL ONCO-NUTRITION AND SUPPLEMENTS MARKET
  • FIGURE 3. SEGMENTATION ONCO-NUTRITION AND SUPPLEMENTS MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN ONCO-NUTRITION AND SUPPLEMENTS MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALONCO-NUTRITION AND SUPPLEMENTS MARKET
  • FIGURE 11. ONCO-NUTRITION AND SUPPLEMENTS MARKET SEGMENTATION, BY BY CANCER TYPE
  • FIGURE 12. ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR BLOOD CANCER, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR LIVER CANCER, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR PANCREATIC CANCER, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR BREAST CANCER, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR HEAD AND NECK CANCER, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR LUNG CANCER, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR STOMACH CANCER, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR GASTROINTESTINAL CANCER, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. ONCO-NUTRITION AND SUPPLEMENTS MARKET SEGMENTATION, BY BY DISTRIBUTION CHANNEL
  • FIGURE 23. ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR HOSPITAL STORES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 24. ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR RETAIL PHARMACY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR ONLINE PHARMACY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 26. ONCO-NUTRITION AND SUPPLEMENTS MARKET SEGMENTATION, BY BY END USER
  • FIGURE 27. ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR HOSPITALS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 28. ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR CANCER CARE CENTERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 29. ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 30. ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR HOMECARE CENTERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 31. ONCO-NUTRITION AND SUPPLEMENTS MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 32. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 33. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 34. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 35. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 36. COMPETITIVE DASHBOARD
  • FIGURE 37. COMPETITIVE HEATMAP: ONCO-NUTRITION AND SUPPLEMENTS MARKET
  • FIGURE 38. Top player positioning, 2022
  • FIGURE 39. ABBOTT LABORATORIES: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 40. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 41. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 42. NESTLE S.A: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 43. NESTLE S.A: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 44. NESTLE S.A: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 45. FRESENIUS KABI AG: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 46. FRESENIUS KABI AG: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 47. FRESENIUS KABI AG: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 48. DANONE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 49. DANONE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 50. DANONE: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 51. B. BRAUN MELSUNGEN AG: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 52. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 53. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 54. GLOBAL HEALTH PRODUCTS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 55. GLOBAL HEALTH PRODUCTS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 56. GLOBAL HEALTH PRODUCTS: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 57. HORMEL FOODS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 58. HORMEL FOODS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 59. HORMEL FOODS: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 60. MEAD JOHNSON NUTRITION COMPANY: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 61. MEAD JOHNSON NUTRITION COMPANY: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 62. MEAD JOHNSON NUTRITION COMPANY: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 63. VICTUS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 64. VICTUS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 65. VICTUS: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 66. MEIJI HOLDINGS.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 67. MEIJI HOLDINGS.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 68. MEIJI HOLDINGS.: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now
RELATED TAGS

Purchase Full Report of
Onco-nutrition And Supplements Market

Start reading.
This Report and over 67,068+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers